Section Arrow
Quote
MRVI.NASDAQ
- Maravai LifeSciences Holdings
Quotes are at least 15-min delayed:2025/03/28 05:26 EDT
Last
 2.35
-0.02 (-0.84%)
Day High 
2.42 
Prev. Close
2.37 
1-M High
3.33 
Volume 
1.69M 
Bid
1.9
Ask
2.45
Day Low
2.3 
Open
2.36 
1-M Low
2.07 
Market Cap 
340.45M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 2.41 
20-SMA 2.64 
50-SMA 3.82 
52-W High 11.555 
52-W Low 2.07 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.05/-0.19
Enterprise Value
703.43M
Balance Sheet
Book Value Per Share
2.26
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
259.19M
Operating Revenue Per Share
3.79
Created with Highstock 5.0.121-min Chart12:0015:002.32.3252.352.3752.42.425etnet.com.hk@copyright
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
OCEAOcean Biomedical0.078-0.0057-6.81%-- 
DRMADermata Therapeutics Inc.1.42+0.07+5.19%-- 
ONCOOnconetix Inc0.1077+0.0017+1.60%-- 
RGLSRegulus Therapeutics1.5+0.21+16.28%-- 
NKTXNkarta1.97+0.6+43.80%-- 
Quotes are at least 15-min delayed：2025/03/28 05:26 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.